Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

304.00p
   
  • Change Today:
      4.50p
  • 52 Week High: 445.00
  • 52 Week Low: 228.50
  • Currency: UK Pounds
  • Shares Issued: 106.00m
  • Volume: 483,236
  • Market Cap: £322.23m
  • RiskGrade: 125

Latest ShareCast News

Oxford Biomedica reports first-half revenue growth

By Josh White

Date: Monday 23 Sep 2024

(Sharecast News) - Oxford Biomedica, a prominent gene and cell therapy company, reported significant revenue growth alongside strategic advancements in its interim results on Monday.

OXB Regulatory News

2025 Annual General Meeting notification 28-Apr-2025 13:00 RNS
Holding(s) in Company 23-Apr-2025 17:45 RNS
Preliminary results for the year ended 31 Dec 2024 09-Apr-2025 07:00 RNS
Holding(s) in Company 04-Apr-2025 08:52 RNS
OXB Total Voting Rights 01-Apr-2025 07:00 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 304.00p
Change Today 4.50p
% Change 1.50 %
52 Week High 445.00
52 Week Low 228.50
Volume 483,236
Shares Issued 106.00m
Market Cap £322.23m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.77% below the market average31.77% below the market average31.77% below the market average31.77% below the market average31.77% below the market average
6.38% below the sector average6.38% below the sector average6.38% below the sector average6.38% below the sector average6.38% below the sector average
Price Trend
16.94% below the market average16.94% below the market average16.94% below the market average16.94% below the market average16.94% below the market average
20.83% above the sector average20.83% above the sector average20.83% above the sector average20.83% above the sector average20.83% above the sector average
Income Not Available
Growth
2.04% below the market average2.04% below the market average2.04% below the market average2.04% below the market average2.04% below the market average
Sector averageSector averageSector averageSector averageSector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 28-Apr-2025

Time Volume / Share Price
15:32 4,727 @ 303.50p
15:32 4,727 @ 303.00p
15:32 4,727 @ 303.50p
15:32 4,727 @ 303.00p
16:37 88,661 @ 304.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page